Biotelemetry reported $-3535000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Addus Homecare ADUS:US $ 21.96M 3.13M
Bioscrip BIOS:US $ 76.35M 8.12M
Biotelemetry BEAT:US $ -3.54M 1.39M
Boston Scientific BSX:US $ 648M 407M
Enzo Biochem ENZ:US $ -1.67M 3.3M
Healius Ltd HLS:AU $ 508.2M 264.4M
HP HPQ:US $ 1585M 59M
IBM IBM:US $ 3771M 779M
Integra Lifesciences IART:US $ 102.81M 9.22M
Masimo MASI:US $ 92.87M 24.12M
Medtronic MDT:US $ 2355M 64M
Microsoft MSFT:US $ 24513M 376M
Omnicell OMCL:US $ 39.35M 9.62M
Sony SNE:US $ 350165M 343744M
Verizon VZ:US $ 11873M 159M